Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kerid Anti-Age Gel is a topical dermatological product developed by Polichem (a subsidiary of Almirall) designed to address signs of skin aging and photo-aging. It is formulated to reduce cutaneous signs of cellular senescence, prevent wrinkle formation, and improve skin hydration and firmness. Clinical observations indicate that the gel reduces skin roughness and pigmentation while enhancing brightness in younger skin and improving firmness in older skin. While positioned as a cosmeceutical or dermatological gel, it has received approved status for the treatment and prevention of skin aging signs. The specific active ingredients and molecular targets are not publicly disclosed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kerid Anti-Age Gel.